Modulation of survivin reverses cardiac and pulmonary remodeling in monocrotaline-induced pulmonary arterial hypertension

被引：0
|
作者：
Ana Filipa Silva, A. F. [1 ]
Ferreira-Pinto, M. J. [1 ]
Justino, J. [2 ]
Nogueira-Ferreira, R. [2 ]
Padrao, A. I. [2 ]
Carneiro, F. [1 ]
Moreira-Goncalves, D. [3 ]
Leite-Moreira, A. F. [1 ]
Henriques-Coelho, T. [1 ]
机构：
[1] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal
[2] Univ Aveiro, QOPNA, P-3800 Aveiro, Portugal
[3] Univ Porto, Fac Sport, Res Ctr Phys Act Hlth & Leisure, P-4100 Oporto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
160
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Survivin Inhibition Reverses Cardiac and Pulmonary Remodeling in Monocrotaline-Induced Pulmonary Arterial Hypertension
    Ferreira-Pinto, Manuel J.
    Silva, Ana Filipa
    Justino, Joana
    Nogueira-Ferreira, Rita
    Padrco, Ana Isabel
    Moreira-Goncalves, Daniel
    Carneiro, Fabio
    Costa, Raquel
    Leite-Moreira, Adelino F.
    Henriques-Coelho, Tiago
    CIRCULATION, 2013, 128 (22)
  • [2] Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats
    Price, L. C.
    Montani, D.
    Tcherakian, C.
    Dorfmueller, P.
    Souza, R.
    Gambaryan, N.
    Chaumais, M-C.
    Shao, D. M.
    Simonneau, G.
    Howard, L. S.
    Adcock, I. M.
    Wort, S. J.
    Humbert, M.
    Perros, F.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (04) : 813 - 822
  • [3] Gp130 inhibitor reduces inflammation and reverses pulmonary arterial remodeling of monocrotaline-induced pulmonary arterial hypertension
    Huang, Z. W.
    Liu, Z. H.
    Luo, Q.
    Zhao, Z. H.
    Zhao, Q.
    Zheng, Y. G.
    Xi, Q. Y.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1062 - 1062
  • [4] Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
    Jung, Christian
    Gruen, Katja
    Betge, Stefan
    Pernow, John
    Kelm, Malte
    Muessig, Johanna
    Masyuk, Maryna
    Kuethe, Friedhelm
    Ndongson-Dongmo, Bernadin
    Bauer, Reinhard
    Lauten, Alexander
    Schulze, P. Christian
    Berndt, Alexander
    Franz, Marcus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [5] Safflower injection inhibits pulmonary arterial remodeling in a monocrotaline-induced pulmonary arterial hypertension rat model
    Chen, Aifeng
    Ding, Shibiao
    Kong, Liangliang
    Xu, Jianpu
    He, Fei
    Ru, Chuhui
    Lin, Xu'ai
    ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES, 2021, 76 (1-2): : 27 - 34
  • [6] Cardiac Glycolytic Metabolism In Monocrotaline-Induced Pulmonary Arterial Hypertension Rats
    Qiu, M. -H.
    Zhang, R.
    Zhang, H. -D.
    Jiang, X.
    Liu, D.
    Jing, Z. -C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
    Cai, Changhong
    Xiang, Yijia
    Wu, Yonghui
    Zhu, Ning
    Zhao, Huan
    Xu, Jian
    Lin, Wensheng
    Zeng, Chunlai
    MOLECULAR MEDICINE REPORTS, 2019, 20 (06) : 4984 - 4992
  • [8] Astragaloside IV blocks monocrotaline-induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling
    Jin, Haifeng
    Jiao, Yu
    Guo, Linna
    Ma, Yong
    Zhao, Rongjie
    Li, Xuemei
    Shen, Lei
    Zhou, Zhongguang
    Kim, Sang Chan
    Liu, Jicheng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (02) : 595 - 606
  • [9] Compound xiebai capsule alleviates pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats
    Wu, Zhouye
    Xi, Zhaoqing
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (01) : 107 - 114
  • [10] Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats
    Li, Huayang
    Liu, Quan
    Yue, Yuan
    Wang, Shunjun
    Huang, Suiqing
    Huang, Lin
    Luo, Li
    Zhang, Yitao
    Wu, Zhongkai
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2022, 12 (01) : 88 - 102
12345